Skip to main content
Top

16-03-2024 | Retinoblastoma | Review Article

Epidemiology, Diagnosis and Genetics of Retinoblastoma: ICMR Consensus Guidelines

Authors: Lata Singh, Girish Chinnaswamy, Rachna Meel, Venkatraman Radhakrishnan, Renu Madan, Suyash Kulkarni, Archana Sasi, Tanvir Kaur, R. S. Dhaliwal, Sameer Bakhshi

Published in: Indian Journal of Pediatrics

Login to get access

Abstract

Retinoblastoma (RB) is the most common intraocular tumor in childhood. It is mainly caused by mutations in both alleles of the RB1 tumor suppressor gene that is found on chromosome 13 and regulates the cell cycle. Approximately 8000 children are diagnosed with RB globally each year, with an estimated 1500 cases occurring in India. The survival rate of RB has improved to more than 90% in the developed world. Leukocoria and proptosis are the most common presenting features of RB in Asian Indian populations. Most cases of RB are diagnosed by fundus examination followed by ultrasound. The International Classification of Retinoblastoma is the most used scheme for the staging and classification of intraocular RB in India. Prenatal testing and preimplantation genetic testing for RB may be beneficial in high-risk families. Histopathologic risk factors such as massive choroidal invasion and post-laminar optic nerve help in predicting the occurrence of metastasis in children with RB, while presence of microscopic residual disease requires aggressive adjuvant treatment in eyes enucleated for group E RB. The review provides a consensus document on diagnosis and genetics of RB in India.
Literature
1.
go back to reference Arora R, Eden T, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer. 2009;46:264–73.CrossRefPubMed Arora R, Eden T, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer. 2009;46:264–73.CrossRefPubMed
2.
go back to reference Broaddus E, Topham A, Singh AD. Survival with retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 2009;93:24–7.CrossRefPubMed Broaddus E, Topham A, Singh AD. Survival with retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 2009;93:24–7.CrossRefPubMed
4.
5.
go back to reference Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129–31.CrossRefPubMed Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129–31.CrossRefPubMed
6.
go back to reference Gupta N, Pandey A, Dimri K, Prinja S. Epidemiological profile of retinoblastoma in North India: implications for primary care and family physicians. J Family Med Prim Care. 2020;9:2843–8.CrossRefPubMedPubMedCentral Gupta N, Pandey A, Dimri K, Prinja S. Epidemiological profile of retinoblastoma in North India: implications for primary care and family physicians. J Family Med Prim Care. 2020;9:2843–8.CrossRefPubMedPubMedCentral
8.
go back to reference Ries LAG, Smith MA, Gurney JG, et al. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975–1995. Bethesda, MD: National Cancer Institute, SEER Program. NIH Pub. No. 99-4649;1999. Ries LAG, Smith MA, Gurney JG, et al. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975–1995. Bethesda, MD: National Cancer Institute, SEER Program. NIH Pub. No. 99-4649;1999.
9.
go back to reference Bakhshi S, Bakhshi R. Genetics and management of retinoblastoma. J Indian Assoc Pediatr Surg. 2007;12:109–15.CrossRef Bakhshi S, Bakhshi R. Genetics and management of retinoblastoma. J Indian Assoc Pediatr Surg. 2007;12:109–15.CrossRef
10.
go back to reference Kapoor G, Arora RS, Radhakrishnan V, et al. Profile of childhood cancers from hospital-based cancer registries in India, 2012-19. Indian Pediatr. 2024;61:39–44.CrossRefPubMed Kapoor G, Arora RS, Radhakrishnan V, et al. Profile of childhood cancers from hospital-based cancer registries in India, 2012-19. Indian Pediatr. 2024;61:39–44.CrossRefPubMed
13.
go back to reference Meel R, Radhakrishnan V, Bakhshi S. Current therapy and recent advances in the management of retinoblastoma. Indian J Med Paediatr Oncol. 2012;33:80–8.CrossRefPubMedPubMedCentral Meel R, Radhakrishnan V, Bakhshi S. Current therapy and recent advances in the management of retinoblastoma. Indian J Med Paediatr Oncol. 2012;33:80–8.CrossRefPubMedPubMedCentral
14.
go back to reference Malhotra RK, Manoharan N, Nair O, Deo SVS, Bakhshi S, Rath GK. Patterns and trends of childhood cancer incidence (0–14 years) in Delhi, India: 1990–2014. Indian Pediatr. 2021;58:430–5.CrossRefPubMed Malhotra RK, Manoharan N, Nair O, Deo SVS, Bakhshi S, Rath GK. Patterns and trends of childhood cancer incidence (0–14 years) in Delhi, India: 1990–2014. Indian Pediatr. 2021;58:430–5.CrossRefPubMed
15.
go back to reference Bakhshi S, Gupta S, Gogia V, Ravindranath Y. Compliance in retinoblastoma. Indian J Pediatr. 2010;77:535–40.CrossRefPubMed Bakhshi S, Gupta S, Gogia V, Ravindranath Y. Compliance in retinoblastoma. Indian J Pediatr. 2010;77:535–40.CrossRefPubMed
16.
go back to reference Chawla B, Hasan F, Azad R, et al. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2016;100:172–8.CrossRefPubMed Chawla B, Hasan F, Azad R, et al. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2016;100:172–8.CrossRefPubMed
18.
go back to reference Kleinerman RA, Yu CL, Little MP, et al. Variation of second cancer risk by family history of retinoblastoma among long-term survivors. J Clin Oncol. 2012;30:950–7.CrossRefPubMedPubMedCentral Kleinerman RA, Yu CL, Little MP, et al. Variation of second cancer risk by family history of retinoblastoma among long-term survivors. J Clin Oncol. 2012;30:950–7.CrossRefPubMedPubMedCentral
19.
go back to reference Nichols KE, Walther S, Chao E, Shields C, Ganguly A. Recent advances in retinoblastoma genetic research. Curr Opin Ophthalmol. 2009;20:351–5.CrossRefPubMed Nichols KE, Walther S, Chao E, Shields C, Ganguly A. Recent advances in retinoblastoma genetic research. Curr Opin Ophthalmol. 2009;20:351–5.CrossRefPubMed
20.
go back to reference Benavente CA, Dyer MA. Genetics and epigenetics of human retinoblastoma. Annu Rev Pathol. 2015;10:547–62.CrossRefPubMed Benavente CA, Dyer MA. Genetics and epigenetics of human retinoblastoma. Annu Rev Pathol. 2015;10:547–62.CrossRefPubMed
21.
go back to reference Rushlow DE, Mol BM, Kennett JY, et al. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol. 2013;14:327–34.CrossRefPubMed Rushlow DE, Mol BM, Kennett JY, et al. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol. 2013;14:327–34.CrossRefPubMed
22.
go back to reference Haik BG, Dunleavy SA, Cooke C, et al. Retinoblastoma with anterior chamber extension. Ophthalmology. 1987;94:367–70.CrossRefPubMed Haik BG, Dunleavy SA, Cooke C, et al. Retinoblastoma with anterior chamber extension. Ophthalmology. 1987;94:367–70.CrossRefPubMed
23.
go back to reference Kaliki S, Shields CL, Cassoux N, et al. Defining high-risk retinoblastoma: a multicenter global survey. JAMA Ophthalmol. 2022;140:30–6.CrossRefPubMed Kaliki S, Shields CL, Cassoux N, et al. Defining high-risk retinoblastoma: a multicenter global survey. JAMA Ophthalmol. 2022;140:30–6.CrossRefPubMed
24.
go back to reference Kashyap S, Sethi S, Meel R, et al. A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country. Arch Pathol Lab Med. 2012;136:190–3.CrossRefPubMed Kashyap S, Sethi S, Meel R, et al. A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country. Arch Pathol Lab Med. 2012;136:190–3.CrossRefPubMed
25.
go back to reference Kaliki S, Srinivasan V, Gupta A, Mishra DK, Naik MN. Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: a case-control study. Ophthalmology. 2015;122:1165–72.CrossRefPubMed Kaliki S, Srinivasan V, Gupta A, Mishra DK, Naik MN. Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: a case-control study. Ophthalmology. 2015;122:1165–72.CrossRefPubMed
26.
go back to reference Sastre X, Chantada GL, Doz F, et al. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009;133:1199–202.CrossRefPubMed Sastre X, Chantada GL, Doz F, et al. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009;133:1199–202.CrossRefPubMed
27.
go back to reference Singh L, Singh MK, Rizvi MA, et al. Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma. Cancer Immunol Immunother. 2020;69:1087–99.CrossRefPubMed Singh L, Singh MK, Rizvi MA, et al. Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma. Cancer Immunol Immunother. 2020;69:1087–99.CrossRefPubMed
28.
go back to reference López López JC, Fernández Alonso N, Cuevas Álvarez J, García-Caballero T, Pastor Jimeno JC. Immunohistochemical assay for neuron-specific enolase, synaptophysin, and RB-associated protein as a diagnostic aid in advanced retinoblastomas. Clin Ophthalmol. 2018;12:1171–9.CrossRefPubMedPubMedCentral López López JC, Fernández Alonso N, Cuevas Álvarez J, García-Caballero T, Pastor Jimeno JC. Immunohistochemical assay for neuron-specific enolase, synaptophysin, and RB-associated protein as a diagnostic aid in advanced retinoblastomas. Clin Ophthalmol. 2018;12:1171–9.CrossRefPubMedPubMedCentral
29.
go back to reference Radhakrishnan V, Kashyap S, Singh L, Pushker N, Bakhshi S. Prognostic significance of VEGF at baseline in orbital retinoblastoma (IRSS stage II and stage III). Pediatr Blood Cancer. 2012;59:769–70.CrossRefPubMed Radhakrishnan V, Kashyap S, Singh L, Pushker N, Bakhshi S. Prognostic significance of VEGF at baseline in orbital retinoblastoma (IRSS stage II and stage III). Pediatr Blood Cancer. 2012;59:769–70.CrossRefPubMed
30.
go back to reference Kashyap S, Meel R, Pushker N, et al. Clinical predictors of high risk histopathology in retinoblastoma. Pediatr Blood Cancer. 2012;58:356–61.CrossRefPubMed Kashyap S, Meel R, Pushker N, et al. Clinical predictors of high risk histopathology in retinoblastoma. Pediatr Blood Cancer. 2012;58:356–61.CrossRefPubMed
31.
go back to reference de Graaf P, Göricke S, Rodjan F, et al. Guidelines for imaging retinoblastoma: imaging principles and MRI standardization. Pediatr Radiol. 2012;42:2–14.CrossRefPubMed de Graaf P, Göricke S, Rodjan F, et al. Guidelines for imaging retinoblastoma: imaging principles and MRI standardization. Pediatr Radiol. 2012;42:2–14.CrossRefPubMed
32.
go back to reference Beets-Tan RG, Hendriks MJ, Ramos LM, Tan KE. Retinoblastoma: CT and MRI. Neuroradiology. 1994;36:59–62.CrossRefPubMed Beets-Tan RG, Hendriks MJ, Ramos LM, Tan KE. Retinoblastoma: CT and MRI. Neuroradiology. 1994;36:59–62.CrossRefPubMed
33.
go back to reference Tomar AS, Finger PT, Gallie B, et al; American Joint Committee on Cancer Ophthalmic Oncology Task Force; American Joint Committee on Cancer Ophthalmic Oncology Task. Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging. Br J Ophthalmol. 2023;107:127–32. Tomar AS, Finger PT, Gallie B, et al; American Joint Committee on Cancer Ophthalmic Oncology Task Force; American Joint Committee on Cancer Ophthalmic Oncology Task. Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging. Br J Ophthalmol. 2023;107:127–32.
34.
go back to reference Bakhshi S, Meel R, Kashyap S, Sharma S. Bone marrow aspirations and lumbar punctures in retinoblastoma at diagnosis: correlation with IRSS staging. J Pediatr Hematol Oncol. 2011;33:e182–5.CrossRefPubMed Bakhshi S, Meel R, Kashyap S, Sharma S. Bone marrow aspirations and lumbar punctures in retinoblastoma at diagnosis: correlation with IRSS staging. J Pediatr Hematol Oncol. 2011;33:e182–5.CrossRefPubMed
35.
go back to reference de Jong MC, Kors WA, de Graaf P, Castelijns JA, Kivelä T, Moll AC. Trilateral retinoblastoma: a systematic review and meta-analysis. Lancet Oncol. 2014;15:1157–67.CrossRefPubMed de Jong MC, Kors WA, de Graaf P, Castelijns JA, Kivelä T, Moll AC. Trilateral retinoblastoma: a systematic review and meta-analysis. Lancet Oncol. 2014;15:1157–67.CrossRefPubMed
36.
37.
go back to reference Sethi RV, Shih HA, Yeap BY, et al. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer. 2014;120:126–33.CrossRefPubMed Sethi RV, Shih HA, Yeap BY, et al. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer. 2014;120:126–33.CrossRefPubMed
38.
go back to reference Mallipatna A, Marino M, Singh AD. Genetics of retinoblastoma. Asia Pac J Ophthalmol. 2016;5:260–4.CrossRef Mallipatna A, Marino M, Singh AD. Genetics of retinoblastoma. Asia Pac J Ophthalmol. 2016;5:260–4.CrossRef
39.
go back to reference Singh L, Saini N, Pushker N, et al. Mutational analysis of the mitochondrial DNA displacement-loop region in human retinoblastoma with patient outcome. Pathol Oncol Res. 2019;25:503–12.CrossRefPubMed Singh L, Saini N, Pushker N, et al. Mutational analysis of the mitochondrial DNA displacement-loop region in human retinoblastoma with patient outcome. Pathol Oncol Res. 2019;25:503–12.CrossRefPubMed
40.
go back to reference Grotta S, D’Elia G, Scavelli R, et al. Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma. BMC Cancer. 2015;15:841.CrossRefPubMedPubMedCentral Grotta S, D’Elia G, Scavelli R, et al. Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma. BMC Cancer. 2015;15:841.CrossRefPubMedPubMedCentral
41.
go back to reference Neriyanuri S, Raman R, Rishi P, Govindasamy K, Ramprasad VL, Sharma T. Prenatal genetic diagnosis of retinoblastoma–clinical correlates on follow-up. Indian J Ophthalmol. 2015;63:741–2.CrossRefPubMedPubMedCentral Neriyanuri S, Raman R, Rishi P, Govindasamy K, Ramprasad VL, Sharma T. Prenatal genetic diagnosis of retinoblastoma–clinical correlates on follow-up. Indian J Ophthalmol. 2015;63:741–2.CrossRefPubMedPubMedCentral
42.
go back to reference Malhotra J, Malhotra K, Majumdar G, et al. Indian Society for Assisted Reproduction consensus guidelines on preimplantation genetic testing in in vitro fertilization clinics. J Hum Reprod Sci. 2021;14:S31–47. Malhotra J, Malhotra K, Majumdar G, et al. Indian Society for Assisted Reproduction consensus guidelines on preimplantation genetic testing in in vitro fertilization clinics. J Hum Reprod Sci. 2021;14:S31–47.
44.
go back to reference Soliman SE, Racher H, Zhang C, MacDonald H, Gallie BL. Genetics and molecular diagnostics in retinoblastoma–an update. Asia Pac J Ophthalmol. 2017;6:197–207. Soliman SE, Racher H, Zhang C, MacDonald H, Gallie BL. Genetics and molecular diagnostics in retinoblastoma–an update. Asia Pac J Ophthalmol. 2017;6:197–207.
Metadata
Title
Epidemiology, Diagnosis and Genetics of Retinoblastoma: ICMR Consensus Guidelines
Authors
Lata Singh
Girish Chinnaswamy
Rachna Meel
Venkatraman Radhakrishnan
Renu Madan
Suyash Kulkarni
Archana Sasi
Tanvir Kaur
R. S. Dhaliwal
Sameer Bakhshi
Publication date
16-03-2024
Publisher
Springer India
Published in
Indian Journal of Pediatrics
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-024-05085-2